1.40
-0.01 (-0.71%)
| Previous Close | 1.41 |
| Open | 1.40 |
| Volume | 753,013 |
| Avg. Volume (3M) | 442,836 |
| Market Cap | 145,720,688 |
| Price / Earnings (Forward) | 6.87 |
| Price / Sales | 0.490 |
| Price / Book | 0.420 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2026 |
| Profit Margin | -206.05% |
| Operating Margin (TTM) | -11.81% |
| Diluted EPS (TTM) | -4.41 |
| Quarterly Revenue Growth (YOY) | -6.80% |
| Total Debt/Equity (MRQ) | 41.43% |
| Current Ratio (MRQ) | 1.75 |
| Operating Cash Flow (TTM) | 67.67 M |
| Levered Free Cash Flow (TTM) | 68.25 M |
| Return on Assets (TTM) | -0.43% |
| Return on Equity (TTM) | -89.99% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | Definitive Healthcare Corp. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Average | 1.00 |
|
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 9.15% |
| % Held by Institutions | 96.92% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Inspire Investing, Llc | 31 Dec 2025 | 698,967 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 3.00 (Canaccord Genuity, 114.29%) | Hold |
| Median | 2.50 (78.57%) | |
| Low | 2.00 (Stephens & Co., 42.86%) | Hold |
| Average | 2.50 (78.57%) | |
| Total | 2 Hold | |
| Avg. Price @ Call | 1.28 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 27 Feb 2026 | 3.00 (114.29%) | Hold | 1.28 |
| Stephens & Co. | 27 Feb 2026 | 2.00 (42.86%) | Hold | 1.28 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 29 Jan 2026 | Announcement | Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast |
| 07 Jan 2026 | Announcement | Definitive Healthcare to Present at the 28th Annual Needham Growth Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |